Designs and manufactures advanced technology for hemostasis, specifically advanced blood clotting technology. NexStat Topical Hemostat Powder is intended for use under the care of a health care professional as a topical dressing for the temporary treatment of moderate to severely bleeding wounds such as surgical wounds (post-operative, donor sites, dermatological), cuts and lacerations and for the treatment of mild bleeding from topical ENT surgical wounds and nosebleeds. It is also indicated for control of bleeding from the skin at percutaneous needle access, vascular and percutaneous catheter access sites. NexFoam is a versatile sponge that can be used as a spacer, stent and hemostat. It dissolves naturally over 7-14 days or can be easily removed with gentle irrigation. Both NexStat and NexFoam are biocompatible and require no special storage conditions.
View Top Employees from Hemostasis, LLCWebsite | http://www.hemostasisllc.com |
Revenue | $5 million |
Funding | $864000 |
Employees | 44 (34 on RocketReach) |
Address | 5000 Township Pkwy, Saint Paul, Minnesota 55110, US |
Phone | (651) 855-1466 |
Fax | (651) 855-1465 |
Technologies |
JavaScript,
HTML,
PHP
+20 more
(view full list)
|
Industry | Retail, Medical Equipment Manufacturing, ENT Surgical; Cath Lab |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular Hemostasis, LLC employee's phone or email?
The Hemostasis, LLC annual revenue was $5 million in 2024.
Michael Spearman is the Co-Founder and Chairman of Hemostasis, LLC.
34 people are employed at Hemostasis, LLC.
Hemostasis, LLC is based in Saint Paul, Minnesota.
The NAICS codes for Hemostasis, LLC are [339, 33].
The SIC codes for Hemostasis, LLC are [38, 384].